These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 316419)

  • 21. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
    Flood PM; Philipps C; Taupier MA; Schreiber H
    J Immunol; 1980 Jan; 124(1):424-30. PubMed ID: 6965296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of theta-like antigen by rat peripheral lymphocytes: serologic and functional studies.
    Douglas TC; Dowsett AP
    J Immunol; 1975 Jul; 115(1):283-8. PubMed ID: 1151060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell surface receptors involved in the attachment of murine cytotoxic T lymphocytes to target cells - a study with xenoantisera to T-cell antigens.
    Rabinowitz R; Levy J; Schlesinger M
    Thymus; 1983 Apr; 5(3-4):127-39. PubMed ID: 6603681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages].
    Nanjo M; Saito M; Aonuma E; Fujimura H; Nakamura T; Aso H; Yoshie O; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):887-93. PubMed ID: 3885861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites.
    Ksander BR; Streilein JW
    J Immunol; 1989 Jul; 143(2):426-31. PubMed ID: 2500481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice.
    Garrido MA; Valdayo MJ; Winkler DF; Titus JA; Hecht TT; Perez P; Segal DM; Wunderlich JR
    Cancer Res; 1990 Jul; 50(14):4227-32. PubMed ID: 2142014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The differentiation of cytotoxic T cells in vitro. III. The role of helper T cells and their products in the differentiation of cytotoxic cells from "memory" cell populations.
    Okada M; Henney CS
    J Immunol; 1980 Aug; 125(2):850-7. PubMed ID: 6446579
    [No Abstract]   [Full Text] [Related]  

  • 34. Soluble factor(s) from LPS-activated macrophages induce cytotoxic T cell differentiation from alloantigen-primed spleen cells.
    Klimpel GR
    J Immunol; 1980 Sep; 125(3):1243-9. PubMed ID: 6967896
    [No Abstract]   [Full Text] [Related]  

  • 35. Involvement of T cells in the recall of Salmonella-induced resistance to tumour.
    Ashley MP; Kotlarski I; Hardy D
    Immunology; 1977 Jan; 32(1):1-10. PubMed ID: 321336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.
    Rosenstein M; Eberlein T; Kemeny MM; Sugarbaker PH; Rosenberg SA
    J Immunol; 1981 Aug; 127(2):566-71. PubMed ID: 7019327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of resistance to the intracellular protozoan Encephalitozoon cuniculi in mice.
    Schmidt EC; Shadduck JA
    J Immunol; 1984 Nov; 133(5):2712-9. PubMed ID: 6434635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of graft-versus-host disease on anti-tumor immunity.
    Schreiber KL; Forman J
    J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between alloantigen responses in nude mice injected with a low number of congenic thymus cells.
    Kindred B; Corley RB; Schirrmacher V
    Thymus; 1980 Sep; 2(2):83-92. PubMed ID: 7003827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.
    Newlands ES; Hay FC; Roitt IM
    Clin Exp Immunol; 1978 Feb; 31(2):189-96. PubMed ID: 306324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.